证券代码：002595 证券简称：豪迈科技 公告编号：2025-047 山东豪迈机械科技股份有限公司 关于2026年度日常关联交易预计的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 一、 日常关联交易基本情况 （一）日常关联交易概述 2025 年 12 月 19 日，山东豪迈机械科技股份有限公司（以下简称"公司"）召开第六届董 事会第二十次会议，审议通过《关于 2026 年度日常关联交易预计的议案》。关联董事单既强先 生、张伟先生、徐德辉先生、刘海涛先生进行了回避表决，该议案以 5 票同意、0 票反对、0 票弃权的结果获得通过。 公司第六届董事会第二十次会议召开前，公司独立董事专门会议审议通过了本议案，全体 独立董事同意将本议案提交董事会审议。 上述议案尚需提交公司 2026 年第一次临时股东会审议，关联股东张恭运先生、柳胜军先 生、单既强先生、张伟先生、徐德辉先生、刘海涛先生等将回避表决。 单位：人民币万元 | 关联交易 | 关联人 | 关联交易内 | 关联交易 | 2026 年度预 | 2025 年 1-11 月 | 2024 年发生 | | | ...

证券代码：002595 证券简称：豪迈科技 公告编号：2025-049 上述授信额度不等于公司实际融资金额，实际融资金额应在授信额度内以银行与公司实际 发生的融资金额为准。 《关于向银行申请综合授信额度的议案》需提交公司股东会审议批准，本次申请授信额度 的期限为自董事会审议通过提交股东会审议批准之日起一年内有效。 二、对本公司的影响 山东豪迈机械科技股份有限公司 关于向银行申请综合授信额度的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏。 一、申请综合授信概述 山东豪迈机械科技股份有限公司（以下简称"公司"）于2025年12月19日召开第六届董事 会第二十次会议，审议通过《关于向银行申请综合授信额度的议案》，具体情况如下： 根据公司经营发展需要，公司拟向相关银行申请总额不超过人民币50亿元的综合授信额度。 公司提请股东会授权管理层办理上述授信事宜，授权公司法定代表人或法定代表人指定的授权 代理人签署上述综合授信额度内的有关文件。公司与相关银行不构成关联关系。 公司本次向银行申请综合授信额度符合公司日常经营业务的需要，有利于保证公司经营业 务的正常开展，不 ...

关于召开2026年第一次临时股东会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 根据山东豪迈机械科技股份有限公司（以下简称"公司"）第六届董事会第二十次会议决议， 公司决定于 2026 年 1 月 8 日（周四）召开 2026 年第一次临时股东会，现将有关事项通知如下： 一、召开会议的基本情况 证券代码：002595 证券简称：豪迈科技 公告编号：2025-051 山东豪迈机械科技股份有限公司 1. 股东会届次：2026 年第一次临时股东会 2. 股东会的召集人：董事会 4. 会议时间： （1）现场会议时间：2026 年 1 月 8 日 14:30。 （2）网络投票时间：通过深圳证券交易所系统进行网络投票的具体时间为 2026 年 1 月 8 日 9:15-9:25，9:30-11:30，13:00-15:00；通过深圳证券交易所互联网投票系统投票的具体时间 为 2026 年 1 月 8 日 9:15 至 15:00 的任意时间。 5. 会议的召开方式：现场表决与网络投票相结合。 6. 会议的股权登记日：2025 年 12 月 31 日 7. 出席对 ...

证券代码：002595 证券简称：豪迈科技 公告编号：2025-046 山东豪迈机械科技股份有限公司 第六届董事会第二十次会议决议的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整， 没有虚假记载、误导性陈述或者重大遗漏。 山东豪迈机械科技股份有限公司（以下简称"公司"）第六届董事会第二十次会议 通知已于2025年12月9日以电子邮件、微信等方式送达各位董事，会议于2025年12月 19日在公司会议室以现场结合通讯表决方式召开，会议应出席董事9人，实际出席9人， 刘志峰先生、马广林先生、王新宇先生、徐德辉先生以通讯方式出席，全体高管列席 了会议。会议由公司董事长单既强先生主持，本次会议的召集、召开符合《公司法》 及《公司章程》的有关规定，会议合法有效。 经与会董事认真讨论，一致通过以下决议： 《关于向银行申请综合授信额度的公告》刊登于《中国证券报》《证券日报》《上 海证券报》《证券时报》及巨潮资讯网（www.cninfo.com.cn），本事项尚需提交2026 年第一次临时股东会审议。 三、会议以9票同意、0票反对、0票弃权的表决结果，审议通过《关于使用闲置 资金进行现金管理的议案》 一、会议以 ...

Core Viewpoint - The company highlighted its main customers in the gas turbine business, which include major industry players such as GE, Mitsubishi, Siemens, Shanghai Electric, Dongfang Electric, and Harbin Electric [1] Group 1 - The company's gas turbine business primarily serves large multinational corporations [1] - Key customers in the gas turbine sector are recognized leaders in the energy and engineering industries [1]

每经AI快讯，豪迈科技（SZ 002595，收盘价：81.64元）发布公告称，2025年12月17日，豪迈科技接受 合远基金等投资者调研，公司证券事务代表赵倩倩参与接待，并回答了投资者提出的问题。 （记者 王瀚黎） 截至发稿，豪迈科技市值为653亿元。 每经头条（nbdtoutiao）——海南封关政策红利全解析：零关税、低个税、投资准入放宽、跨境资金自 由、创业扶持…… 2025年1至6月份，豪迈科技的营业收入构成为：轮胎生产专用设备制造业占比51.99%，大型燃气轮机 零部件加工占比36.98%，数控机床占比9.62%，其他业务占比1.41%。 ...

Group 1: Tire Mould Business - The pricing mechanism for tire moulds considers specifications, difficulty, complexity, and order cycles, with profit margins linked to product type and complexity [2] - Tire moulds are replaced either due to reaching their lifespan or due to design updates, with lifespan influenced by material, processing technology, and usage methods [2] - The overseas production capacity for tire moulds accounts for approximately 10% of total mould capacity, with facilities established in countries like the USA, Thailand, and Hungary [2] Group 2: CNC Machine Tool Business - Since launching in 2022, the CNC machine tool products have seen repeat orders, with sales primarily in five-axis machining centers and other advanced machinery [3] - For the period from January to September 2025, the CNC machine tool segment achieved approximately CNY 800 million in revenue [3] - The production capacity for large component machinery is expanding, with a new 70,000-ton casting capacity being developed [3] Group 3: Gas Turbine and Wind Power Business - Major clients for the gas turbine business include GE, Mitsubishi, and Siemens [4] - Wind power product prices fluctuate with the market, while gas turbine prices remain relatively stable [4] - The global demand for gas turbines is expected to grow, with the company currently operating at full capacity [4] Group 4: Cost Structure - In 2024, raw materials account for about one-third of the costs in the tire mould business, while in large component machinery, the proportion is around 50% [4] - Key raw materials for tire moulds include forged steel and aluminum ingots, while large component machinery primarily uses pig iron and scrap steel [4] Group 5: Corporate Strategy - There are currently no plans to inject associated company businesses into the listed company, with any future developments to be disclosed as required [5]

Investment Rating - The industry is rated as "Positive" for the next 12 months, indicating an expected increase of over 10% relative to the CSI 300 index [35] Core Views - The demand for engineering machinery is expected to continue growing due to favorable domestic construction activity and the implementation of significant investment projects as outlined in the "14th Five-Year Plan" [2][27] - In November, the production of industrial robots reached approximately 70,200 units, marking a year-on-year increase of 20.60%, with expectations for total production to exceed 700,000 units in 2025 [2][27] - The report maintains "Buy" ratings for specific companies including Zoomlion (000157), Hengli Hydraulic (601100), Jiechang Drive (603583), and Haomai Technology (002595) [2][27] Industry News - In November, sales of various types of forklifts reached 119,749 units, a year-on-year increase of 14.1% [10] - The domestic sales of forklifts for the first 11 months of 2025 totaled 843,005 units, reflecting a growth of 14.3% [10] - Beijing Zhuoyue Intelligent Technology Co., Ltd. successfully completed a strategic financing round of 200 million yuan [11] - Hitachi Construction Machinery will change its name to LANDCROS, pending shareholder approval [11] Industry Data - As of December 12, 2025, the comprehensive steel price index (CSPI) was recorded at 91.76 [12] - WTI and Brent crude oil prices were reported at $56.82 and $60.56 per barrel, respectively, as of December 16, 2025 [13] Company Announcements - Suzhou Sileck Precision Equipment Co., Ltd. announced a partnership with investment institutions to enhance project reserves and overall competitiveness [17] - Wuxi Chemical Equipment Co., Ltd. plans to establish a wholly-owned subsidiary in South Korea with an investment of up to $100,000 [18] Market Review - From December 10 to December 16, 2025, the CSI 300 index fell by 2.19%, while the machinery equipment sector declined by 2.95%, underperforming the CSI 300 by 0.76 percentage points [19] - The price-to-earnings ratio (PE, TTM) for the machinery equipment sector was 43.94 times, with a valuation premium of 218.89% relative to the CSI 300 [20]

Group 1 - The core viewpoint of the article highlights the target price increases for several listed companies as of December 15, with notable gains in the pharmaceutical and automation sectors [1][5]. - The companies with the highest target price increases include Zejing Pharmaceutical at 35.00%, Zoli Pharmaceutical at 34.58%, and Genesis at 27.40%, indicating strong bullish sentiment in the chemical pharmaceutical, traditional Chinese medicine, and automation equipment industries respectively [1][5]. - A total of 21 listed companies received broker recommendations on December 15, with Zoli Pharmaceutical receiving the most recommendations at 5, while companies like Tiandi Technology and Changbao Co. received 1 recommendation each [6]. Group 2 - On December 15, brokers initiated coverage on 7 companies, with Changbao Co. receiving an "Accumulate" rating from China Merchants Securities, Genesis receiving a "Outperform" rating from China International Capital Corporation, and SAIC Motor receiving a "Buy" rating from Aijian Securities [3][7]. - The newly covered companies include Changbao Co. in the special steel industry, Genesis in the automation equipment sector, and SAIC Motor in the passenger vehicle market, indicating a diverse range of industries being targeted for investment [4][8].

Core Insights - On December 15, 2023, brokerage firms provided target prices for listed companies, with notable increases for Zejing Pharmaceutical, Zoli Pharmaceutical, and Genesis, showing target price increases of 35.00%, 34.58%, and 27.40% respectively, across the chemical pharmaceuticals, traditional Chinese medicine, and automation equipment industries [1][2]. Group 1: Target Price Increases - Zejing Pharmaceutical received a target price increase of 35.00%, with a latest closing price of 135.00 yuan [2]. - Zoli Pharmaceutical's target price increased by 34.58%, with a closing price of 17.18 yuan [2]. - Genesis saw a target price increase of 27.40%, with a closing price of 11.30 yuan [2]. Group 2: Brokerage Recommendations - A total of 21 listed companies received brokerage recommendations on December 15, with Zoli Pharmaceutical receiving the highest number of recommendations at 5 [3]. - Other companies like Tiandi Technology and Changbao Co. received 1 recommendation each [3]. Group 3: First Coverage Ratings - On December 15, 7 companies received initial coverage from brokerages, including Changbao Co. with an "Accumulate" rating from China Merchants Securities [4]. - Genesis received a "Outperform Industry" rating from China International Capital Corporation [4]. - SAIC Motor was rated "Buy" by Aijian Securities [4].